Search - tctmd.com

Displaying 241 - 260 of 406

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2020

Shelley Wood

June 04, 2020

News Daily News

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

Todd Neale

May 21, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2020

Shelley Wood

May 01, 2020

News Daily News

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

L.A. McKeown

April 21, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Features

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Yael L. Maxwell

March 24, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Opinion Editor's Corner

COVID-19 and the Heart: Insights From the Front Lines

Shelley Wood

March 12, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

Shelley Wood

January 31, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for July 2020

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Higher Risk of HF After ACS for Women Previously on Beta-blockers

TCTMD’s Top 10 Most Popular Stories for May 2020

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

TCTMD’s Top 10 Most Popular Stories for April 2020

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Missed Opportunities: Many HF Patients Not Tested for CAD

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

COVID-19 and the Heart: Insights From the Front Lines

TCTMD’s Top 10 Most Popular Stories for February 2020

Trials of New Cancer Drugs Failing to Address Potential CV Risks

TCTMD’s Top 10 Most Popular Stories for January 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content